title: MET in ovarian cancer: metastasis and resistance?
authors.affiliation: Department of Radiation Oncology; The University of Texas MD Anderson Cancer Center; Houston, TX USA.
authors.forename: Chad
authors.initials: C
authors.lastname: Tang
authors.affiliation: Investigational Cancer Therapeutics; The University of Texas MD Anderson Cancer Center; Houston, TX USA.
authors.forename: Denis L
authors.initials: DL
authors.lastname: Jardim
authors.affiliation: Investigational Cancer Therapeutics; The University of Texas MD Anderson Cancer Center; Houston, TX USA.
authors.forename: David
authors.initials: D
authors.lastname: Hong
mesh_terms: D019008:Drug Resistance, Neoplasm; D005260:Female; D006801:Humans; D009362:Neoplasm Metastasis; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology; D011110:Polymorphism, Genetic; D019859:Proto-Oncogene Proteins c-met / Q000235:genetics / Q000378:metabolism*; D015398:Signal Transduction
chemical_list: C491743:MET protein, human; D019859:Proto-Oncogene Proteins c-met
keywords: c-Met; genetic amplification; genetic mutation; ovarian cancer; phase I trials